Peptide Guide
Ipamorelin Before and After 90 Day Update
Executive Brief
Ipamorelin is a selective growth hormone secretagogue that stimulates your pituitary gland to release more GH without spiking cortisol or prolactin. A 90-day protocol is the most common timeframe users commit to, and the results follow a predictable pattern: sleep improvements first, then body composition changes, then recovery and energy gains. This page covers what to expect week by week, real user experiences, and what the research says about timelines. ---
GH pulsatile release
Where ipamorelin came from
Ipamorelin was developed by Novo Nordisk in the late 1990s as a more selective alternative to GHRP-6 and GHRP-2. Those earlier growth hormone releasing peptides worked, but they also stimulated cortisol and prolactin release, which caused unwanted side effects like increased appetite, water retention, and potential cortisol elevation over time. Novo Nordisk wanted a peptide that would trigger growth hormone release through the ghrelin receptor without the hormonal collateral damage. Ipamorelin was the result. It binds to the ghrelin receptor in the pituitary gland and stimulates a clean pulse of growth hormone that mimics the body's natural release pattern. The peptide went through preclinical development but was never brought to market as a pharmaceutical. It ended up in the research peptide space and became one of the most popular GH secretagogues for wellness and anti-aging protocols. Its clean side effect profile and reliable GH stimulation are the main reasons for its popularity.
How ipamorelin works
Ipamorelin works by mimicking ghrelin, the hunger hormone, at the pituitary gland. When it binds to the ghrelin receptor, it signals the pituitary to release stored growth hormone into the bloodstream. This release follows a pulsatile pattern similar to what your body does naturally during deep sleep. Unlike older GHRP peptides, ipamorelin does not significantly raise cortisol or prolactin. This is its main advantage. Cortisol elevation from other GH peptides can cause fat retention, poor sleep, and mood issues, which defeats the purpose of a growth hormone protocol. Ipamorelin avoids this problem. The growth hormone released by ipamorelin does its work through downstream pathways. It stimulates the liver to produce IGF-1, which is the primary mediator of GH's anabolic and regenerative effects. IGF-1 promotes protein synthesis, cell growth, fat metabolism, and tissue repair throughout the body. Ipamorelin is almost always paired with CJC-1295 without DAC, which is a GHRH analog. Together, they stimulate GH release through two different pathways simultaneously, producing a larger and more sustained GH pulse than either one alone. The combination is the standard protocol for most users.
Sleep
Recovery
What actually happens over 90 days
The 90-day ipamorelin timeline follows a predictable progression. Knowing what to expect at each stage helps you assess whether the protocol is working for you. Weeks 1 to 2: Sleep improvements are the first change most users notice. Deeper sleep, fewer nighttime awakenings, and feeling more rested in the morning. Some users notice this within the first few days. The GH pulse from ipamorelin enhances the natural GH surge that occurs during deep sleep, amplifying its restorative effects. Weeks 2 to 4: Recovery from exercise improves. Muscle soreness resolves faster, and you can train harder without accumulating fatigue. Skin may start looking slightly better as collagen turnover increases. Energy levels during the day become more stable. Weeks 4 to 8: Body composition changes begin. Fat loss, particularly around the midsection, starts to become visible. Muscle fullness increases, not from dramatic growth but from improved protein synthesis and water retention in muscle tissue. Nails and hair grow faster and may look healthier. Weeks 8 to 12: The compounding effects become obvious. Body composition is noticeably different, sleep quality is consistently better, joint stiffness has decreased, and overall energy and wellbeing are elevated. IGF-1 levels, if tested, will show a measurable increase from baseline. Not everyone experiences all of these changes. Response depends on age, baseline GH levels, diet, exercise, sleep habits, and individual physiology. People over 40 with lower baseline GH tend to see more dramatic results than younger users with already-optimal GH levels.
How it feels
A user on r/Peptides shared their 90-day update: “I started ipamorelin/CJC at 43 years old. First two weeks, sleep was the only change, but it was significant. I was sleeping through the night for the first time in years. Around week four I noticed I was not as sore after lifting. By month two my wife commented that my face looked leaner. At 90 days I had lost about 8 pounds of fat and gained maybe 2 pounds of muscle. My IGF-1 went from 145 to 210. Nothing dramatic, just steady improvement.“ Another user on r/Peptides noted: “I did 90 days of ipamorelin 200 mcg with CJC-1295 100 mcg at bedtime. Sleep was better immediately. The body composition stuff took longer, maybe 6 weeks to really notice. My biggest surprise was my skin. It looked healthier, smoother, like I was using some kind of expensive product. I was not. Just the peptides. Recovery at the gym was noticeably better by week three.“ The consensus across user reports is that patience matters. People who quit at 30 days because they did not see dramatic changes often miss the real benefits that show up between weeks 6 and 12.
Benefits you will notice
- Deeper, more restorative sleep within the first one to two weeks
- Faster recovery from exercise and physical activity
- Gradual fat loss, particularly around the midsection
- Improved skin quality, texture, and hydration
- Faster nail and hair growth
- Increased energy and reduced afternoon fatigue
- Reduced joint stiffness and improved mobility
- Measurable increase in IGF-1 levels on blood work
Peptides that pair well with ipamorelin
CJC-1295 without DAC is the standard pairing and is used by the vast majority of ipamorelin users. The combination produces a stronger GH pulse than ipamorelin alone. Standard dosing is 100 to 200 mcg of each, injected subcutaneously at bedtime. BPC-157 can be added for tissue repair and gut health. The peptides operate through different pathways and complement each other well, especially for users with joint issues or digestive problems. GHK-Cu can be added for enhanced skin benefits. Since ipamorelin already improves skin through GH-mediated collagen production, adding GHK-Cu's direct copper peptide effects can amplify the cosmetic results. AOD-9604 is sometimes stacked for users who want additional fat loss on top of the GH-mediated metabolic improvements. This adds another fat mobilization pathway without interfering with ipamorelin's mechanism.
Frequently Asked Questions
What is the standard ipamorelin dosing for a 90-day protocol?
Most users inject 200 to 300 mcg of ipamorelin alongside 100 to 200 mcg of CJC-1295 without DAC, once or twice daily. The most common timing is once at bedtime to amplify the natural nighttime GH pulse. Some users add a second dose in the morning or post-workout. Injections are subcutaneous, typically in the abdomen.
Do I need to cycle ipamorelin or can I run it continuously?
Most protocols involve a 90-day on, 30-day off cycle. Some users run it for 6 months continuously. There is no strong evidence that cycling is required for safety, but breaks allow your pituitary to return to baseline and let you assess whether the benefits persist without the peptide. Long-term continuous use has not been well studied in humans.
What side effects should I expect?
Ipamorelin is one of the mildest GH secretagogues. The most common side effect is increased hunger, especially in the first hour after injection. Some users report mild water retention or tingling in the hands, which is a sign of GH activity. Headaches can occur in the first week. Cortisol and prolactin elevation is minimal compared to other GHRPs.
Can women use ipamorelin?
Yes. Women use ipamorelin at the same or slightly lower doses than men. The peptide does not have hormonal effects beyond GH stimulation, so it does not interfere with the menstrual cycle, birth control, or hormone replacement therapy. Women often report better sleep and skin benefits as the primary improvements.
How do I know if my ipamorelin is working?
The best objective measure is IGF-1 blood testing before starting and at 6 to 8 weeks. A meaningful increase confirms the peptide is stimulating GH release. Subjective markers to track include sleep quality, exercise recovery, body measurements, and energy levels. If you feel nothing and your IGF-1 has not changed after 8 weeks, your peptide may be underdosed or degraded.
Research Disclaimer
All content on this page is provided for informational and research purposes only. Nothing here constitutes medical advice, diagnosis, or treatment recommendation. Always consult a qualified healthcare professional before using any compound.